How High Will Rubrik Stock Go?
Shares of cybersecurity company Rubrik (NYSE:RBRK) have been on a…
Buy
54
ACN Quote, Financials, Valuation and Earnings
Last price:
$378.35
Seasonality move
:
1.34%
Day range:
$358.93 - $373.85
52-week range:
$278.69 - $387.51
Dividend yield:
1.49%
P/E ratio:
31.30x
P/S ratio:
3.57x
P/B ratio:
8.00x
Volume:
3.9M
Avg. volume:
2.7M
1-year change:
0.56%
Market cap:
$233.4B
Revenue:
$64.9B
EPS (TTM):
$11.92
Analysts' Opinion
-
Consensus RatingAccenture PLC has received a consensus rating of Buy. The company's average rating is a Buy based on 12 Buy ratings, 8 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $395.20, Accenture PLC has an estimated upside of 5.91% from its current price of $373.15.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $323.00 representing 100% downside risk from its current price of $373.15.
Fair Value
-
According to the consensus of 20 analysts, Accenture PLC has 5.91% upside to fair value with a price target of $395.20 per share.
ACN vs. S&P 500
-
Over the past 5 trading days, Accenture PLC has overperformed the S&P 500 by 7.14% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Accenture PLC does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Accenture PLC has grown year-over-year revenues for 2 quarters straight. In the most recent quarter Accenture PLC reported revenues of $17.7B.
Earnings Growth
-
Accenture PLC has grown year-over-year earnings for 2 quarters straight. In the most recent quarter Accenture PLC reported earnings per share of $3.59.
Enterprise value:
231.2B
EV / Invested capital:
6.56x
Price / LTM sales:
3.57x
EV / EBIT:
22.86x
EV / Revenue:
3.48x
PEG ratio (5yr expected):
2.99x
EV / Free cash flow:
25.53x
Price / Operating cash flow:
26.18x
Enterprise value / EBITDA:
19.97x
Gross Profit (TTM):
$21.5B
Return On Assets:
13.88%
Net Income Margin (TTM):
11.41%
Return On Equity:
26.41%
Return On Invested Capital:
24.98%
Operating Margin:
16.67%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-11-30 | 2023-11-30 | 2024-11-30 | 2023-11-30 | 2024-11-30 | |
| Income Statement | ||||||
| Revenue | $62.4B | $64.6B | $66.4B | $16.2B | $17.7B | |
| Gross Profit | $20B | $21B | $21.5B | $5.4B | $5.8B | |
| Operating Income | $9.5B | $8.8B | $10B | $2.6B | $2.9B | |
| EBITDA | $10.8B | $10.6B | $11.6B | $3B | $3.4B | |
| Diluted EPS | $11.01 | $10.79 | $11.92 | $3.10 | $3.59 | |
| Period Ending | 2020-11-30 | 2021-11-30 | 2022-11-30 | 2023-11-30 | 2024-11-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $18.6B | $18.6B | $20.7B | $23.1B | $25.2B | |
| Total Assets | $38.3B | $43.7B | $47.1B | $51.5B | $59.9B | |
| Current Liabilities | $12.8B | $15.2B | $16.5B | $17.3B | $17.2B | |
| Total Liabilities | $19.8B | $22.7B | $23.4B | $24B | $29.8B | |
| Total Equity | $18.4B | $20.9B | $23.7B | $27.5B | $30.1B | |
| Total Debt | $68.8M | $65M | $54.6M | $147.1M | $5.2B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-11-30 | 2023-11-30 | 2024-11-30 | 2023-11-30 | 2024-11-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $9.5B | $9.5B | $9.7B | $498.6M | $1B | |
| Cash From Investing | -$3.1B | -$2.7B | -$6.6B | -$855.4M | -$385.5M | |
| Cash From Financing | -$5.9B | -$5.5B | -$1.8B | -$1.6B | $2.8B | |
| Free Cash Flow | $8.9B | $9B | $9.1B | $429.6M | $870.3M | |
ACN
Sector
Market Cap
$233.4B
$112.4M
Price % of 52-Week High
96.29%
66.94%
Dividend Yield
1.49%
0%
Shareholder Yield
2.28%
0.91%
1-Year Price Total Return
0.56%
-4.76%
Beta (5-Year)
1.236
0.912
Dividend yield:
1.49%
Annualized payout:
$5.16
Payout ratio:
44.35%
Growth streak:
13 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$358.40
200-day SMA
Buy
Level
$333.44
Bollinger Bands (100)
Buy
Level
346.36 - 365
Chaikin Money Flow
Buy
Level
1.2B
20-day SMA
Buy
Level
$355.21
Relative Strength Index (RSI14)
Buy
Level
66.34
ADX Line
Buy
Level
13.74
Williams %R
Sell
Level
-2.3745
50-day SMA
Buy
Level
$358.08
MACD (12, 26)
Buy
Level
1.63
25-day Aroon Oscillator
Sell
Level
-56
On Balance Volume
Neutral
Level
868.3M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (7.1474)
Buy
CA Score
(Annual)
Level (0.8484)
Buy
Beneish M-Score
(Annual)
Level (-2.4423)
Buy
Momentum Score
Level (6)
Buy
Ohlson Score
Level (-2.1896)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (10)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Accenture is a leading global IT services firm that provides consulting, strategy, and technology and operational services. These services run the gamut from aiding enterprises with digital transformation to procurement services to software system integration. The company provides its IT offerings to a variety of sectors, including communications, media and technology, financial services, health and public services, consumer products, and resources. Accenture employs just under 500,000 people throughout 200 cities in 51 countries.
Stock Forecast FAQ
In the current month, ACN has received 12 Buy ratings 8 Hold ratings, and 0 Sell ratings. The ACN average analyst price target in the past 3 months is $395.20.
-
Where Will Accenture PLC Stock Be In 1 Year?
According to analysts, the consensus estimate is that Accenture PLC share price will rise to $395.20 per share over the next 12 months.
-
What Do Analysts Say About Accenture PLC?
Analysts are divided on their view about Accenture PLC share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Accenture PLC is a Sell and believe this share price will drop from its current level to $323.00.
-
What Is Accenture PLC's Price Target?
The price target for Accenture PLC over the next 1-year time period is forecast to be $395.20 according to 20 Wall Street analysts, 12 of them rate the stock a Buy, 0 rate the stock a Sell, and 8 analysts rate the stock a Hold.
-
Is ACN A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Accenture PLC is a Buy. 12 of 20 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of ACN?
You can purchase shares of Accenture PLC via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Accenture PLC shares.
-
What Is The Accenture PLC Share Price Today?
Accenture PLC was last trading at $378.35 per share. This represents the most recent stock quote for Accenture PLC. Yesterday, Accenture PLC closed at $373.15 per share.
-
How To Buy Accenture PLC Stock Online?
In order to purchase Accenture PLC stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Stanley Druckenmiller’s Portfolio Playbook: Lessons from a Billionaire Investor
Stanley Druckenmiller may be best known for his role with…
Is Intuitive Machines on Sale?
In 2024, Intuitive Machines (NASDAQ:LUNR) hit an out-of-this-world milestone when…
Stock Ideas
Buy
52
Is AAPL Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 38x
Buy
54
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Sell
37
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 99x
Alerts
Buy
59
AKRO alert for Jan 28
Akero Therapeutics [AKRO] is down 0.39% over the past day.
Sell
23
NBIS alert for Jan 28
Nebius Group NV [NBIS] is up 15.34% over the past day.
Sell
36
CRDO alert for Jan 28
Credo Technology Group Holding [CRDO] is up 4.66% over the past day.
